Lonafarnib

Lonafarnib, sold under the brand name Zokinvy, is a medication used to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies in people one year of age and older. It is under trial for its use as combination ...

1 story • Updated Oct 17, 2025
Lonafarnib
Science

"Longevity Gene Breakthrough Offers New Hope for Children with Progeria"

6 sources Oct 15, 2025